iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDB) Stock Price Down 0.3% – What’s Next?

Shares of iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDBGet Free Report) fell 0.3% on Thursday . The company traded as low as $35.26 and last traded at $35.29. 15,156 shares changed hands during trading, a decline of 24% from the average session volume of 19,857 shares. The stock had previously closed at $35.39.

iShares LifePath Target Date 2030 ETF Trading Down 0.3%

The stock has a market capitalization of $76.93 million, a P/E ratio of 20.07 and a beta of 0.57. The company has a fifty day simple moving average of $34.91 and a two-hundred day simple moving average of $34.13.

Hedge Funds Weigh In On iShares LifePath Target Date 2030 ETF

Institutional investors and hedge funds have recently made changes to their positions in the company. Capital Advisors Ltd. LLC grew its position in shares of iShares LifePath Target Date 2030 ETF by 21.8% in the 1st quarter. Capital Advisors Ltd. LLC now owns 3,430 shares of the company’s stock valued at $112,000 after purchasing an additional 613 shares during the period. Rothschild Investment LLC bought a new position in iShares LifePath Target Date 2030 ETF in the fourth quarter valued at $148,000. Finally, Susquehanna International Group LLP acquired a new stake in shares of iShares LifePath Target Date 2030 ETF in the third quarter valued at about $335,000.

About iShares LifePath Target Date 2030 ETF

(Get Free Report)

The iShares LifePath Target Date 2030 ETF (ITDB) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2030 ITDB was launched on Oct 17, 2023 and is issued by BlackRock.

Featured Stories

Receive News & Ratings for iShares LifePath Target Date 2030 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2030 ETF and related companies with MarketBeat.com's FREE daily email newsletter.